Literature DB >> 11263506

The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.

S L Hwang1, Y H Yang, A S Lieu, M C Chuang, S J Chang, Y Y Chang, H J Lin, S L Howng.   

Abstract

BACKGROUND: Relative survival rates can offer a general description of tumor outcome and, traditionally, are used for surveillance and comparison purposes. However, they are not informative for individual tumor survivors. Conditional survival estimates can calculate the probability of surviving next some years given survival to a specific period of time after craniotomy for individual tumor survivors. However, clinically, they have not been used for predicting the tumor outcome.
METHODS: We calculated conditional probabilities of survival within 6 years after craniotomy in 112 patients with primary supratentorial astrocytic tumors and evaluated factors affecting the survival time more than 2 years after craniotomy.
RESULTS: Our data showed that the conditional probability of survival can predict yearly survival rate when patients survive for a specific period of time. The conditional survival rates within 6 years after craniotomy were always higher than those evaluated by relative survival rates. Overall, the longer the patients survived, the higher the conditional probabilities of surviving sixth year postoperatively were.
CONCLUSION: Our study demonstrates the conditional probabilities of survival have good availability and are important estimates for individual tumor survivors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11263506     DOI: 10.1023/a:1006484220764

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  The role of radiation therapy in the treatment of astrocytomas.

Authors:  S A Leibel; G E Sheline; W M Wara; E B Boldrey; S L Nielsen
Journal:  Cancer       Date:  1975-06       Impact factor: 6.860

2.  Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.

Authors:  S V Rajkumar; J C Buckner; P J Schomberg; J M Reid; P J Bagniewski; M M Ames; T L Cascino; R S Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

3.  Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

Authors:  F Cohadon; N Aouad; A Rougier; C Vital; J Rivel; J F Dartigues
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

4.  Conditional survival among patients with carcinoma of the lung.

Authors:  R M Merrill; D E Henson; M Barnes
Journal:  Chest       Date:  1999-09       Impact factor: 9.410

5.  The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.

Authors:  L Kleinberg; S A Grossman; S Piantadosi; M Zeltzman; M Wharam
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

6.  Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors.

Authors:  P J Miller; R S Hassanein; P G Giri; B F Kimler; P O'Boynick; R G Evans
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-08       Impact factor: 7.038

7.  A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.

Authors:  C Dazzi; A Cariello; M Giannini; M Del Duca; P Giovanis; G Fiorentini; M Leoni; G Rosti; D Turci; A Tienghi; B Vertogen; F Zumaglini; U De Giorgi; M Marangolo
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

Review 8.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

9.  Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.

Authors:  M Huncharek; J Muscat
Journal:  Anticancer Res       Date:  1998 Mar-Apr       Impact factor: 2.480

10.  The treatment of adult supratentorial high grade astrocytomas.

Authors:  G G Duncan; G B Goodman; C M Ludgate; D E Rheaume
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

View more
  12 in total

1.  Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000-2008.

Authors:  Y Yuan; J Ross; Q Shi; F G Davis
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

2.  Conditional survival in gastric cancer: a SEER database analysis.

Authors:  Samuel J Wang; Rachel Emery; Clifton D Fuller; Jong-Sung Kim; Dean F Sittig; Charles R Thomas
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

3.  Conditional survival of all primary brain tumor patients by age, behavior, and histology.

Authors:  Kimberly R Porter; Bridget J McCarthy; Michael L Berbaum; Faith G Davis
Journal:  Neuroepidemiology       Date:  2011-06-16       Impact factor: 3.282

4.  An interactive tool for individualized estimation of conditional survival in rectal cancer.

Authors:  Samuel J Wang; Amanda R Wissel; Join Y Luh; C David Fuller; Jayashree Kalpathy-Cramer; Charles R Thomas
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

5.  Conditional probability of survival in patients with newly diagnosed glioblastoma.

Authors:  Mei-Yin C Polley; Kathleen R Lamborn; Susan M Chang; Nicholas Butowski; Jennifer L Clarke; Michael Prados
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.

Authors:  Yan Xing; George J Chang; Chung-Yuan Hu; Robert L Askew; Merrick I Ross; Jeffrey E Gershenwald; Jeffrey E Lee; Paul F Mansfield; Anthony Lucci; Janice N Cormier
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

7.  Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program.

Authors:  Ann C Mertens; Jian Yong; Andrew C Dietz; Erin Kreiter; Yutaka Yasui; Archie Bleyer; Gregory T Armstrong; Leslie L Robison; Karen Wasilewski-Masker
Journal:  Cancer       Date:  2014-12-29       Impact factor: 6.860

8.  Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.

Authors:  Beth A Zamboni; Greg Yothers; Mehee Choi; Clifton D Fuller; James J Dignam; Peter C Raich; Charles R Thomas; Michael J O'Connell; Norman Wolmark; Samuel J Wang
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

9.  Conditional Survival in Rectal Cancer: A SEER Database Analysis.

Authors:  Samuel J Wang; Clifton D Fuller; Rachel Emery; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2007-05

10.  Long-term mortality among women with epithelial ovarian cancer.

Authors:  Helen E Dinkelspiel; Miriam Champer; June Hou; Ana Tergas; William M Burke; Yongmei Huang; Alfred I Neugut; Cande V Ananth; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2015-06-05       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.